Patients should seek immediate medical attention for severe, persistent abdominal pain (potential pancreatitis), right upper quadrant pain/fever/jaundice (potential gallbladder disease), signs of allergic reaction, or symptoms of dehydration or kidney problems
Excellent communication, product arrived timely and accurately
While theyre fundamentally similar medications, they differ slightly in their mechanism of action: Wegovy (semaglutide) is a GLP-1 agonist Zepbound (tirzepatide) is a dual agonist: GLP-1 + a glucose-dependent insulinotropic polypeptide (GIP) Both semaglutide and tirzepatide affect the hypothalamus and the hedonic eating centers, the brains center of appetite and cravings
1st of its kind The FDA just approved the first ever GLP-1 pill for weight loss, according to a Novo Nordisk, the makers of Wegovy, news release
The GLP-1 headache guide provides comprehensive management strategies